![MDS prognosis calculator that combines genomic profiling with hematologic and cytogenetic parameters](https://oncodaily.com/pub/uploads/2024/06/photo1718206320.jpeg)
Jun 15, 2024, 06:34
MDS prognosis calculator that combines genomic profiling with hematologic and cytogenetic parameters
The IPSS-M is the newest MDS prognosis calculator that combines genomic profiling with hematologic and cytogenetic parameters, improving the risk stratification of patients with MDS.
This is a valuable tool for clinical decision-making, offering the prospect of tailoring diagnosis and therapeutic interventions to each patient’s molecular profile.
Click here to access the calculator.